PG
PG icon

Prostatis Group’s Procter & Gamble PG Stock Holding History

Prostatis Group’s Portfolio PG Stock Details PG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233K Buy
+1,589
New +$231K 0.05% 166
2025
Q4 		– Sell
-1,998
Closed -$307K – 177
2025
Q3 		$307K Sell
1,998
-306
-13% -$47.8K 0.08% 126
2025
Q2 		$367K Sell
2,304
-335
-13% -$54.7K 0.11% 108
2025
Q1 		$450K Sell
2,639
-191
-7% -$32K 0.14% 98
2024
Q4 		$474K Sell
2,830
-407
-13% -$69.3K 0.14% 106
2024
Q3 		$561K Sell
3,237
-561
-15% -$95.2K 0.18% 89
2024
Q2 		$626K Buy
3,798
+79
+2% +$12.9K 0.22% 86
2024
Q1 		$603K Sell
3,719
-3,106
-46% -$487K 0.23% 84
2023
Q4 		$1M Buy
6,825
+340
+5% +$50.4K 0.42% 57
2023
Q3 		$967K Sell
6,485
-577,276
-99% -$88.2M 0.47% 44
2023
Q2 		$868K Buy
583,761
+578,154
+10,311% +$87.1M 0.4% 55
2023
Q1 		$842K Buy
5,607
+3,462
+161% +$495K 0.44% 54
2022
Q4 		$325K Buy
2,145
+87
+4% +$12.2K 0.2% 74
2022
Q3 		$260K Buy
2,058
+17
+0.8% +$2.42K 0.3% 47
2022
Q2 		$293K Buy
2,041
+102
+5% +$15.3K 0.46% 24
2022
Q1 		$296K Sell
1,939
-45
-2% -$7.04K 0.24% 60
2021
Q4 		$325K Buy
1,984
+105
+6% +$15.6K 0.2% 68
2021
Q3 		$263K Sell
1,879
-45
-2% -$6.38K 0.16% 83
2021
Q2 		$260K Buy
1,924
+239
+14% +$32.3K 0.18% 87
2021
Q1 		$228K Buy
1,685
+52
+3% +$6.79K 0.18% 87
2020
Q4 		$227K Sell
1,633
-358
-18% -$50K 0.19% 73
2020
Q3 		$277K Sell
1,991
-112
-5% -$14.9K 0.26% 66
2020
Q2 		$251K Buy
2,103
+155
+8% +$18.1K 0.51% 55
2020
Q1 		$214K Sell
1,948
-114
-6% -$13.7K 0.3% 50
2019
Q4 		$258K Buy
+2,062
New +$252K 0.23% 74

Other funds holding PG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Prostatis Group's PG Position: Q2 2026 in Review

Prostatis Group opened a new position in Procter & Gamble (PG) in Q2 2026: 1,589 shares worth $233K. The stake represents 0.05% of the portfolio and ranks #166 among its holdings. This is a return to the name: Prostatis Group previously reported a position in PG as recently as Q3 2025.

Prostatis Group first reported a position in PG in Q4 2019 and has held it in 25 quarters since. The position peaked at $1M in Q4 2023. 4,006 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Prostatis Group held 1,589 shares of Procter & Gamble worth $233K as of Q2 2026.
  • Procter & Gamble was a new Prostatis Group position in Q2 2026.
  • Procter & Gamble made up 0.05% of Prostatis Group's portfolio in Q2 2026, its #166 holding.
  • Prostatis Group first reported a position in Procter & Gamble in Q4 2019 and has held it in 25 quarters since.
  • Prostatis Group's Procter & Gamble position peaked at $1M in Q4 2023.
  • 4,006 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.